<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Johnson, Teddi Dineley</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Next generation of flu vaccines coming of age: Cell-based technology may replace egg-based flu vaccines</style></title><secondary-title><style face="normal" font="default" size="100%">The Nation's Health</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-02-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1-27</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><issue><style face="normal" font="default" size="100%">1</style></issue><abstract><style  face="normal" font="default" size="100%">With the reliability of a finely tuned clock, seasonal influenza returns each year, causing about 36,000 U.S. deaths and incalculable misery. Not as reliable has been the availability of the most important tool for controlling flu: vaccines.Copyright The Nation’s Health, American Public Health Association</style></abstract></record></records></xml>